Richard M. Jelinek

Richard M. Jelinek, listed as chief executive, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Evolent Health, Inc., Aetna Inc /PA/ and Blue Owl Capital Inc. In total, 13 filings cover trades dated from 27 December 2017 to 4 June 2026.

On the market, this insider has only ever bought: 2 purchases, €254k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants and 4 option exercises.

On 8 June 2026 came the latest disclosure, a share grant in Evolent Health, Inc. The clock since the last published purchase (10 March 2025) now reads 592 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.